nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—Prostatic hypertrophy—Furosemide—dilated cardiomyopathy	0.15	0.179	CcSEcCtD
Dicyclomine—Benign prostatic hyperplasia—Furosemide—dilated cardiomyopathy	0.0817	0.0971	CcSEcCtD
Dicyclomine—Thrombosis—Furosemide—dilated cardiomyopathy	0.02	0.0238	CcSEcCtD
Dicyclomine—Lethargy—Spironolactone—dilated cardiomyopathy	0.0193	0.0229	CcSEcCtD
Dicyclomine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.015	0.0179	CcSEcCtD
Dicyclomine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0146	0.0173	CcSEcCtD
Dicyclomine—Lightheadedness—Furosemide—dilated cardiomyopathy	0.0127	0.0151	CcSEcCtD
Dicyclomine—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.0119	0.0141	CcSEcCtD
Dicyclomine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0106	0.0126	CcSEcCtD
Dicyclomine—Lethargy—Furosemide—dilated cardiomyopathy	0.0105	0.0125	CcSEcCtD
Dicyclomine—Malaise—Spironolactone—dilated cardiomyopathy	0.0103	0.0122	CcSEcCtD
Dicyclomine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00978	0.0116	CcSEcCtD
Dicyclomine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00958	0.0114	CcSEcCtD
Dicyclomine—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00951	0.0113	CcSEcCtD
Dicyclomine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00937	0.0111	CcSEcCtD
Dicyclomine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00929	0.011	CcSEcCtD
Dicyclomine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00907	0.0108	CcSEcCtD
Dicyclomine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00895	0.0106	CcSEcCtD
Dicyclomine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00847	0.0101	CcSEcCtD
Dicyclomine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00826	0.00982	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00802	0.00954	CcSEcCtD
Dicyclomine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00793	0.00942	CcSEcCtD
Dicyclomine—Diplopia—Lisinopril—dilated cardiomyopathy	0.00772	0.00917	CcSEcCtD
Dicyclomine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00766	0.0091	CcSEcCtD
Dicyclomine—Face oedema—Lisinopril—dilated cardiomyopathy	0.00745	0.00886	CcSEcCtD
Dicyclomine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00738	0.00878	CcSEcCtD
Dicyclomine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00697	0.00829	CcSEcCtD
Dicyclomine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00685	0.00814	CcSEcCtD
Dicyclomine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00665	0.00791	CcSEcCtD
Dicyclomine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00657	0.00782	CcSEcCtD
Dicyclomine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00643	0.00764	CcSEcCtD
Dicyclomine—Erythema—Furosemide—dilated cardiomyopathy	0.00619	0.00736	CcSEcCtD
Dicyclomine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00614	0.0073	CcSEcCtD
Dicyclomine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00614	0.0073	CcSEcCtD
Dicyclomine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00591	0.00702	CcSEcCtD
Dicyclomine—Rash—Spironolactone—dilated cardiomyopathy	0.00586	0.00696	CcSEcCtD
Dicyclomine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00585	0.00696	CcSEcCtD
Dicyclomine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00584	0.00694	CcSEcCtD
Dicyclomine—Headache—Spironolactone—dilated cardiomyopathy	0.00582	0.00692	CcSEcCtD
Dicyclomine—Agitation—Furosemide—dilated cardiomyopathy	0.00569	0.00677	CcSEcCtD
Dicyclomine—Nausea—Spironolactone—dilated cardiomyopathy	0.00552	0.00656	CcSEcCtD
Dicyclomine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00531	0.00632	CcSEcCtD
Dicyclomine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00516	0.00613	CcSEcCtD
Dicyclomine—Confusional state—Furosemide—dilated cardiomyopathy	0.0051	0.00606	CcSEcCtD
Dicyclomine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00506	0.00601	CcSEcCtD
Dicyclomine—Shock—Furosemide—dilated cardiomyopathy	0.00497	0.00591	CcSEcCtD
Dicyclomine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00496	0.00589	CcSEcCtD
Dicyclomine—Anorexia—Furosemide—dilated cardiomyopathy	0.00482	0.00573	CcSEcCtD
Dicyclomine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00481	0.00572	CcSEcCtD
Dicyclomine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00468	0.00556	CcSEcCtD
Dicyclomine—Erythema—Lisinopril—dilated cardiomyopathy	0.00465	0.00553	CcSEcCtD
Dicyclomine—Tension—Lisinopril—dilated cardiomyopathy	0.00456	0.00542	CcSEcCtD
Dicyclomine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00454	0.0054	CcSEcCtD
Dicyclomine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00451	0.00537	CcSEcCtD
Dicyclomine—Somnolence—Furosemide—dilated cardiomyopathy	0.00449	0.00534	CcSEcCtD
Dicyclomine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00439	0.00522	CcSEcCtD
Dicyclomine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00438	0.00521	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00436	0.00519	CcSEcCtD
Dicyclomine—Fatigue—Furosemide—dilated cardiomyopathy	0.00436	0.00518	CcSEcCtD
Dicyclomine—Pain—Furosemide—dilated cardiomyopathy	0.00432	0.00514	CcSEcCtD
Dicyclomine—Constipation—Furosemide—dilated cardiomyopathy	0.00432	0.00514	CcSEcCtD
Dicyclomine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00431	0.00513	CcSEcCtD
Dicyclomine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00425	0.00505	CcSEcCtD
Dicyclomine—Malaise—Lisinopril—dilated cardiomyopathy	0.00419	0.00498	CcSEcCtD
Dicyclomine—Syncope—Lisinopril—dilated cardiomyopathy	0.00417	0.00495	CcSEcCtD
Dicyclomine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00417	0.00495	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00413	0.00491	CcSEcCtD
Dicyclomine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00411	0.00488	CcSEcCtD
Dicyclomine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00408	0.00486	CcSEcCtD
Dicyclomine—Urticaria—Furosemide—dilated cardiomyopathy	0.00402	0.00477	CcSEcCtD
Dicyclomine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.004	0.00475	CcSEcCtD
Dicyclomine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00391	0.00465	CcSEcCtD
Dicyclomine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00387	0.0046	CcSEcCtD
Dicyclomine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00382	0.00455	CcSEcCtD
Dicyclomine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00379	0.00451	CcSEcCtD
Dicyclomine—Oedema—Lisinopril—dilated cardiomyopathy	0.00379	0.00451	CcSEcCtD
Dicyclomine—Shock—Lisinopril—dilated cardiomyopathy	0.00373	0.00444	CcSEcCtD
Dicyclomine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00372	0.00443	CcSEcCtD
Dicyclomine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.0037	0.0044	CcSEcCtD
Dicyclomine—Asthenia—Furosemide—dilated cardiomyopathy	0.00363	0.00431	CcSEcCtD
Dicyclomine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00362	0.0043	CcSEcCtD
Dicyclomine—Pruritus—Furosemide—dilated cardiomyopathy	0.00358	0.00425	CcSEcCtD
Dicyclomine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00343	0.00408	CcSEcCtD
Dicyclomine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00341	0.00405	CcSEcCtD
Dicyclomine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00338	0.00402	CcSEcCtD
Dicyclomine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00337	0.00401	CcSEcCtD
Dicyclomine—Dizziness—Furosemide—dilated cardiomyopathy	0.00334	0.00397	CcSEcCtD
Dicyclomine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00334	0.00397	CcSEcCtD
Dicyclomine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.0033	0.00392	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00327	0.00389	CcSEcCtD
Dicyclomine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00327	0.00389	CcSEcCtD
Dicyclomine—Constipation—Lisinopril—dilated cardiomyopathy	0.00324	0.00386	CcSEcCtD
Dicyclomine—Pain—Lisinopril—dilated cardiomyopathy	0.00324	0.00386	CcSEcCtD
Dicyclomine—CHRM2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00323	0.0204	CbGpPWpGaD
Dicyclomine—Vomiting—Furosemide—dilated cardiomyopathy	0.00321	0.00382	CcSEcCtD
Dicyclomine—Rash—Furosemide—dilated cardiomyopathy	0.00319	0.00379	CcSEcCtD
Dicyclomine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00318	0.00379	CcSEcCtD
Dicyclomine—Headache—Furosemide—dilated cardiomyopathy	0.00317	0.00376	CcSEcCtD
Dicyclomine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00313	0.00372	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.0031	0.00369	CcSEcCtD
Dicyclomine—CHRM1—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00302	0.019	CbGpPWpGaD
Dicyclomine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00301	0.00358	CcSEcCtD
Dicyclomine—Nausea—Furosemide—dilated cardiomyopathy	0.003	0.00357	CcSEcCtD
Dicyclomine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.003	0.00356	CcSEcCtD
Dicyclomine—CYP1A1—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.00294	0.0185	CbGpPWpGaD
Dicyclomine—CYP1A1—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00288	0.0181	CbGpPWpGaD
Dicyclomine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.00287	0.0181	CbGpPWpGaD
Dicyclomine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00279	0.00332	CcSEcCtD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00277	0.0174	CbGpPWpGaD
Dicyclomine—CHRM1—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00275	0.0173	CbGpPWpGaD
Dicyclomine—CHRM3—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00274	0.0173	CbGpPWpGaD
Dicyclomine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00272	0.00324	CcSEcCtD
Dicyclomine—CHRM2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00272	0.0171	CbGpPWpGaD
Dicyclomine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00268	0.00319	CcSEcCtD
Dicyclomine—CHRM1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00265	0.0167	CbGpPWpGaD
Dicyclomine—CHRM3—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00264	0.0167	CbGpPWpGaD
Dicyclomine—CHRM2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00262	0.0165	CbGpPWpGaD
Dicyclomine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00251	0.00298	CcSEcCtD
Dicyclomine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00241	0.00287	CcSEcCtD
Dicyclomine—Rash—Lisinopril—dilated cardiomyopathy	0.00239	0.00284	CcSEcCtD
Dicyclomine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00239	0.00284	CcSEcCtD
Dicyclomine—Headache—Lisinopril—dilated cardiomyopathy	0.00238	0.00282	CcSEcCtD
Dicyclomine—Nausea—Lisinopril—dilated cardiomyopathy	0.00225	0.00268	CcSEcCtD
Dicyclomine—CHRM1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00223	0.014	CbGpPWpGaD
Dicyclomine—CHRM3—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00222	0.014	CbGpPWpGaD
Dicyclomine—CHRM2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0022	0.0139	CbGpPWpGaD
Dicyclomine—CHRM1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00207	0.0131	CbGpPWpGaD
Dicyclomine—CHRM3—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00207	0.013	CbGpPWpGaD
Dicyclomine—CHRM2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00205	0.0129	CbGpPWpGaD
Dicyclomine—CHRM1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00202	0.0127	CbGpPWpGaD
Dicyclomine—CYP1A1—Oxidative Stress—SOD2—dilated cardiomyopathy	0.00201	0.0127	CbGpPWpGaD
Dicyclomine—CHRM3—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00201	0.0127	CbGpPWpGaD
Dicyclomine—CHRM2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00199	0.0125	CbGpPWpGaD
Dicyclomine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.00198	0.0125	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00197	0.0124	CbGpPWpGaD
Dicyclomine—CYP1A1—Oxidative Stress—GPX1—dilated cardiomyopathy	0.00192	0.0121	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00167	0.0105	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00167	0.0105	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00165	0.0104	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00153	0.00962	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00152	0.00959	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00151	0.0095	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.0015	0.00943	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00148	0.00933	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00133	0.00835	CbGpPWpGaD
Dicyclomine—CYP1A1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00127	0.00802	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00117	0.0074	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00116	0.00732	CbGpPWpGaD
Dicyclomine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00098	0.00617	CbGpPWpGaD
Dicyclomine—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000977	0.00615	CbGpPWpGaD
Dicyclomine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000968	0.00609	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000829	0.00522	CbGpPWpGaD
Dicyclomine—CHRM1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000809	0.0051	CbGpPWpGaD
Dicyclomine—CHRM3—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000807	0.00508	CbGpPWpGaD
Dicyclomine—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000799	0.00503	CbGpPWpGaD
Dicyclomine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000794	0.005	CbGpPWpGaD
Dicyclomine—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000792	0.00499	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000789	0.00497	CbGpPWpGaD
Dicyclomine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000784	0.00494	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00077	0.00485	CbGpPWpGaD
Dicyclomine—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000747	0.0047	CbGpPWpGaD
Dicyclomine—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000747	0.0047	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000741	0.00467	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000702	0.00442	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0007	0.0044	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000698	0.0044	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000696	0.00438	CbGpPWpGaD
Dicyclomine—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000694	0.00437	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000693	0.00436	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000668	0.0042	CbGpPWpGaD
Dicyclomine—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000661	0.00416	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000652	0.00411	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00065	0.00409	CbGpPWpGaD
Dicyclomine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000647	0.00407	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000644	0.00406	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000632	0.00398	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00063	0.00397	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000624	0.00393	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000624	0.00393	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000622	0.00392	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000617	0.00388	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000615	0.00387	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000609	0.00383	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000601	0.00379	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000601	0.00379	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000599	0.00377	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000599	0.00377	CbGpPWpGaD
Dicyclomine—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000595	0.00374	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000594	0.00374	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000594	0.00374	CbGpPWpGaD
Dicyclomine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000582	0.00366	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000569	0.00358	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000569	0.00358	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000559	0.00352	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000557	0.00351	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000552	0.00347	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000541	0.00341	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000541	0.00341	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000541	0.00341	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00054	0.0034	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00054	0.0034	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000538	0.00339	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000534	0.00336	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000533	0.00335	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000512	0.00322	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00051	0.00321	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000505	0.00318	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000495	0.00312	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000491	0.00309	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00049	0.00308	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000462	0.00291	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000461	0.0029	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000458	0.00288	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000458	0.00288	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000456	0.00287	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000456	0.00287	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000456	0.00287	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000452	0.00285	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000452	0.00285	CbGpPWpGaD
Dicyclomine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000445	0.0028	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000442	0.00278	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000439	0.00277	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000439	0.00276	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000438	0.00276	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000437	0.00275	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000433	0.00273	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000426	0.00268	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000424	0.00267	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00042	0.00265	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.000416	0.00262	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000412	0.0026	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000411	0.00259	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000409	0.00257	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000408	0.00257	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000407	0.00256	CbGpPWpGaD
Dicyclomine—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000404	0.00254	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000404	0.00254	CbGpPWpGaD
Dicyclomine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000401	0.00253	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.000376	0.00237	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000352	0.00222	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000351	0.00221	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000351	0.00221	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000348	0.00219	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000334	0.0021	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000333	0.0021	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	0.00033	0.00208	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00033	0.00208	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000325	0.00205	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000324	0.00204	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000321	0.00202	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000305	0.00192	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000304	0.00191	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	0.000299	0.00188	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00028	0.00177	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00028	0.00176	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000277	0.00174	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000259	0.00163	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000259	0.00163	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000258	0.00162	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000258	0.00162	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000255	0.00161	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000255	0.00161	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000254	0.0016	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000248	0.00156	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000247	0.00155	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000245	0.00154	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000241	0.00151	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00024	0.00151	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000237	0.0015	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000235	0.00148	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000235	0.00148	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000234	0.00147	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000234	0.00147	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000233	0.00147	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000232	0.00146	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000232	0.00146	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000232	0.00146	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00023	0.00145	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000218	0.00138	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000218	0.00137	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000216	0.00136	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000212	0.00133	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000211	0.00133	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000209	0.00132	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000209	0.00131	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000208	0.00131	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000199	0.00125	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000198	0.00125	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000196	0.00124	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000189	0.00119	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000188	0.00118	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000186	0.00117	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000182	0.00115	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000181	0.00114	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00018	0.00113	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000178	0.00112	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000177	0.00112	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000171	0.00108	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000171	0.00108	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000169	0.00107	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00016	0.00101	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000156	0.000984	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000156	0.000981	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000154	0.000972	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000147	0.000923	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000146	0.00092	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000145	0.000911	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00014	0.000882	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00014	0.000879	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000139	0.000874	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000139	0.000874	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000138	0.000871	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000138	0.000871	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000138	0.00087	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000137	0.000863	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000137	0.000863	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000133	0.000838	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000133	0.000835	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000131	0.000827	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000129	0.000812	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000129	0.00081	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000127	0.000802	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000127	0.000801	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000127	0.000798	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000126	0.00079	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000125	0.000787	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000125	0.000784	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000123	0.000777	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000107	0.000672	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000106	0.00067	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000105	0.000663	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	0.000102	0.000643	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000101	0.000638	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000101	0.000636	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.0001	0.000629	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CD36—dilated cardiomyopathy	9.94e-05	0.000626	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AGT—dilated cardiomyopathy	8.95e-05	0.000564	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.82e-05	0.000556	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.8e-05	0.000554	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.71e-05	0.000548	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.7e-05	0.000548	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.67e-05	0.000546	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.59e-05	0.000541	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	8.11e-05	0.000511	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	7.9e-05	0.000497	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	7.86e-05	0.000495	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	7.84e-05	0.000493	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	7.76e-05	0.000489	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	7.51e-05	0.000473	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	7.49e-05	0.000471	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	7.41e-05	0.000467	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	7.11e-05	0.000448	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.05e-05	0.000381	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.03e-05	0.00038	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.97e-05	0.000376	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	5.21e-05	0.000328	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	5.2e-05	0.000327	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	5.15e-05	0.000324	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	3.57e-05	0.000225	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	3.56e-05	0.000224	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.53e-05	0.000222	CbGpPWpGaD
